XENO

Xeno Transplants Corporation XENO

XENO
Xeno Transplants Corporation XENE
Xenon Pharmaceuticals Inc. PFND
Pathfinder Cell Therapy, Inc. SGBI
Sangui Biotech International, Inc. PROT
Proteonomix, Inc. OMMH
Omnimmune Holdings, Inc. ARNI
Arno Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XENO XENE PFND SGBI PROT OMMH ARNI
6M 0.00 % 23.94 % 0.00 % 0.00 % 900.00 % 0.00 % 0.00 %
YTD 0.00 % 1.91 % 0.00 % 0.00 % 900.00 % 0.00 % 0.00 %
1Y 0.00 % 0.56 % 0.00 % -86.67 % 900.00 % 0.00 % -66.67 %
3Y -50.00 % 17.77 % 0.00 % -98.32 % 0.00 % 0.00 % 9 900.00 %
5Y -98.00 % 274.20 % -96.67 % -99.47 % -93.33 % 0.00 % -93.33 %
10Y -97.44 % 324.66 % -98.75 % -99.78 % -83.33 % 0.00 % -99.97 %
From the beginning -99.90 % 289.88 % -99.97 % -99.96 % -100.00 % 0.00 % -100.00 %

Dividend